# Ping An Biomedical Co. Ltd. (PASW)

Source: https://www.quantisnow.com/company/PASW
Generated: 2026-11-09T12:58:56.404Z

- Ticker: PASW
- Exchange: NASDAQ
- Sector: Consumer Discretionary
- Industry: Apparel
- IPO year: 1999
- SEC CIK: 0001897532

## Latest PASW news and filings

- 2026-11-05 13:45 UTC [SEC Form 6-K] [SEC Form 6-K filed by Ping An Biomedical Co. Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-ping-an-biomedical-co-ltd-6775071)
- 2026-11-04 18:30 UTC [Ping An Biomedical Enters into Patent Purchase Agreement with Future Biotechnology Group for Tumor Cell Technologies](https://www.quantisnow.com/insight/ping-an-biomedical-enters-into-patent-purchase-agreement-with-future-6771944)
- 2026-10-30 20:33 UTC [SEC Form 6-K] [SEC Form 6-K filed by Ping An Biomedical Co. Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-ping-an-biomedical-co-ltd-6765434)
- 2026-10-26 12:30 UTC [SEC Form 6-K] [SEC Form 6-K filed by Ping An Biomedical Co. Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-ping-an-biomedical-co-ltd-6757176)
- 2026-10-23 21:00 UTC [SEC Form F-3 filed by Ping An Biomedical Co. Ltd.](https://www.quantisnow.com/insight/sec-form-f-3-filed-by-ping-an-biomedical-co-ltd-6756540)
- 2026-10-22 21:00 UTC [SEC Form 6-K] [SEC Form 6-K filed by Ping An Biomedical Co. Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-ping-an-biomedical-co-ltd-6755481)
- 2026-10-22 19:30 UTC [Ping An Biomedical Announces Planned Acquisition of Three Tumor Cell-Related Medical Technology Patents to Build a Core Oncology and Biotech Intellectual Property Portfolio](https://www.quantisnow.com/insight/ping-an-biomedical-announces-planned-acquisition-of-three-tumor-cell-related-6754935)
- 2026-10-21 15:00 UTC [SEC Form 6-K] [SEC Form 6-K filed by Ping An Biomedical Co. Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-ping-an-biomedical-co-ltd-6753255)
- 2026-10-21 15:00 UTC [Ping An Biomedical Announces 1-for-40 Reverse Stock Split](https://www.quantisnow.com/insight/ping-an-biomedical-announces-1-for-40-reverse-stock-split-6753250)
- 2026-09-11 13:00 UTC [SEC Form 6-K] [SEC Form 6-K filed by Ping An Biomedical Co. Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-ping-an-biomedical-co-ltd-6712610)
- 2026-08-07 20:30 UTC [SEC Form 6-K] [SEC Form 6-K filed by Ping An Biomedical Co. Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-ping-an-biomedical-co-ltd-6671804)
- 2026-07-22 15:17 UTC [SEC Form 6-K] [SEC Form 6-K filed by Ping An Biomedical Co. Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-ping-an-biomedical-co-ltd-6644950)
- 2026-07-20 13:25 UTC [SEC Form 6-K] [SEC Form 6-K filed by Ping An Biomedical Co. Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-ping-an-biomedical-co-ltd-6642177)
- 2026-05-27 21:00 UTC [SEC Form 6-K] [SEC Form 6-K filed by Ping An Biomedical Co. Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-ping-an-biomedical-co-ltd-6575286)
- 2026-04-08 11:33 UTC [SEC Form 3] [SEC Form 3 filed by new insider Liu Pijun (Pjl)](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-liu-pijun-pjl-6492172)
- 2026-04-01 10:05 UTC [SEC Form 3] [SEC Form 3 filed by new insider Liu Xianzhi (Xzl)](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-liu-xianzhi-xzl-6480498)
- 2026-04-01 10:04 UTC [SEC Form 3] [SEC Form 3 filed by new insider Yang Hongli (Hly)](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-yang-hongli-hly-6480488)
- 2026-03-19 14:49 UTC [SEC Form 6-K] [SEC Form 6-K filed by Ping An Biomedical Co. Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-ping-an-biomedical-co-ltd-6461043)
- 2026-03-19 14:00 UTC [All Resolutions Passed at Ping An Biomedical AGM, Clearing Path for Restructured Share Capital](https://www.quantisnow.com/insight/all-resolutions-passed-at-ping-an-biomedical-agm-clearing-path-6461005)
- 2026-03-18 14:33 UTC [SEC Form 3] [SEC Form 3 filed by Ping An Biomedical Co. Ltd.](https://www.quantisnow.com/insight/sec-form-3-filed-by-ping-an-biomedical-co-ltd-6456269)
- 2026-03-18 13:44 UTC [SEC Form 3] [SEC Form 3 filed by Ping An Biomedical Co. Ltd.](https://www.quantisnow.com/insight/sec-form-3-filed-by-ping-an-biomedical-co-ltd-6456057)
- 2026-03-09 16:01 UTC [SEC Form 6-K] [SEC Form 6-K filed by Ping An Biomedical Co. Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-ping-an-biomedical-co-ltd-6436714)
- 2026-02-27 05:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Ping An Biomedical Co. Ltd.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-ping-an-biomedical-co-ltd-6417725)
- 2026-02-13 21:52 UTC [SEC Form F-1] [SEC Form F-1 filed by Ping An Biomedical Co. Ltd.](https://www.quantisnow.com/insight/sec-form-f-1-filed-by-ping-an-biomedical-co-ltd-6392976)
- 2026-02-12 21:30 UTC [SEC Form 6-K] [SEC Form 6-K filed by Ping An Biomedical Co. Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-ping-an-biomedical-co-ltd-6389956)
- 2026-01-30 19:11 UTC [SEC Form 20-F filed by Ping An Biomedical Co. Ltd.](https://www.quantisnow.com/insight/sec-form-20-f-filed-by-ping-an-biomedical-co-ltd-6367579)
- 2026-01-12 15:09 UTC [SEC Form 6-K] [SEC Form 6-K filed by Ping An Biomedical Co. Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-ping-an-biomedical-co-ltd-6346057)
- 2026-01-09 14:25 UTC [Ping An Biomedical Co., Ltd Announces Strategic Investment in Future Biotechnology Group to Advance Collaborative Development of the Biopharmaceutical Industry](https://www.quantisnow.com/insight/ping-an-biomedical-co-ltd-announces-strategic-investment-in-future-6344093)
- 2026-01-09 12:05 UTC [Ping An Biomedical Co., Ltd. Receives Strategic Investment from Leading Industry Capital, Accelerating Growth in Biopharmaceutical Innovation](https://www.quantisnow.com/insight/ping-an-biomedical-co-ltd-receives-strategic-investment-from-leading-6343801)
- 2025-11-28 11:18 UTC [SEC Form 6-K] [SEC Form 6-K filed by Ping An Biomedical Co. Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-ping-an-biomedical-co-ltd-6295955)
- 2025-11-28 11:00 UTC [Ping An Biomedical Co., Ltd. Announces Receipt of Nasdaq Minimum Bid Price Deficiency Letter](https://www.quantisnow.com/insight/ping-an-biomedical-co-ltd-announces-receipt-of-nasdaq-minimum-6295871)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/PASW
- Earnings history: https://www.quantisnow.com/earnings/PASW
- Dividend history: https://www.quantisnow.com/dividends/PASW
- Insider transactions: https://www.quantisnow.com/insiders/PASW
- Options chain: https://www.quantisnow.com/options/PASW
- SEC 8-K filings only: https://www.quantisnow.com/company/PASW/8-k
- RSS and alerts for PASW: https://www.quantisnow.com/docs/rss-feeds.md